NMC Health Plc reiterated earnings guidance for the fiscal year 2019. Continued strong operational performance in second half of 2019 provides NMC's management confidence in the full year guidance. Revenues expected to be USD 2,500 to USD 2,540 million on Post-IFRS 16 basis and Pre-IFRS 16 basis. Net income to equity holders is expected to be USD 297 to USD 305 million on Post-IFRS 16 basis and USD 320 to USD 330 million on Pre-IFRS 16 basis. For the fiscal year, the company expects existing revenues of USD 2,800 to USD 2,860 million and USD 2,845 to USD 2,915 million on Combined basis.